Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market was valued at USD 0.08 Billion in 2022 and is projected to reach USD 0.11 Billion by 2030, growing at a CAGR of 4.0% from 2024 to 2030.
The Japan 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) market is segmented based on various applications, catering to distinct groups and needs within the healthcare sector. One of the primary applications is in the elderly population, who are at a heightened risk for pneumococcal diseases. The vaccine is crucial for preventing invasive pneumococcal diseases such as pneumonia, bacteremia, and meningitis among older adults. This demographic is particularly vulnerable due to age-related declines in immune function, making vaccination a critical preventive measure. The increased awareness and emphasis on geriatric health have contributed to the robust growth of this segment within the market.
Another significant application of the PPSV23 vaccine is for individuals with chronic conditions, including diabetes, cardiovascular diseases, and chronic respiratory illnesses. People with these chronic conditions are at an increased risk of severe pneumococcal infections, making the vaccine an essential component of their health management plans. Healthcare providers often recommend vaccination as a preventive measure to reduce the risk of complications and hospitalizations related to pneumococcal diseases. The focus on managing chronic illnesses and preventing associated complications drives the demand for pneumococcal vaccines in this segment.
Get an In-Depth Research Analysis of the Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Size And Forecast [2025-2032]
MSD
Sanofipasteur
CDIBP
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market
For Children (2-10)
For Person (10-64)
For The Old (>65)
Based on Types the Market is categorized into Below types that held the largest 23-Valent Pneumococcal Polysaccharide Vaccine market share In 2023.
Single Dose Vial
Pre-filled Syringe
Japan (United States, Japan and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Analysis
1. Introduction of the Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Type
6. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Application
7. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Geography
Japan
Europe
Asia Pacific
Rest of the World
8. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Japan Research and Consulting firm servicing over 5000+ Japan clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/